Stock Analysis·← Pickers

MMED

MiniMed Group, Inc. Common Stock

MiniMed Group, Inc. Common Stock (MMED) is currently in a range/mixed trend. RSI is at 57.1, with 1/3 trend checks passing.

Price
$15.42
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
57.1
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

MMED with MA50 and MA200

18.4916.5714.6412.7210.8003/0604/0805/1106/1107/15
MMED2026-03-062026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$13.44+14.76% vs price
MA200
Distance unavailable
RSI (14)
57.1Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for MMED

MiniMed Group, Inc. Common Stock (MMED) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $15.42, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 14.8%.

Momentum and stretch context

MMED currently has an RSI reading of 57.1, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the MMED chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About MiniMed Group, Inc. Common Stock

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Que Thanh Dallara
Employees
8,000
Market cap
$4.33B
Beta
-3.63
52-week range
$10.65 – $20.48
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
5 Mar 2026
ISIN
US60365F1093
CUSIP
60365F109
Company profile data from Financial Modeling Prep. MMED listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about MMED

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.